Subscribe for stories that matter!
John Witkowski has been appointed as the new CEO of Solesis, a Telford-based company specializing in biomaterials for medical devices and biopharmaceuticals, writes John…
Newtown-based Onconova Therapeutics is joining forces in a major merger deal with drug development company, Trawsfynydd Therapeutics, writes John George for the Philadelphia Business…
Doylestown-based Aprea Therapeutics, a leader in precision oncology, has successfully secured a financing deal anticipated to bring in up to $34 million in proceeds…
Yardley-based Optinose, known for its drug-device product Xhance, is at a pivotal moment as it awaits a decision from the Food and Drug…
Abington biochemist Katalin Karikó recently published a new book, Breaking Through: My Life in Science, which provides a vivid account of her life and decades…
A new initiative has been launched at the University of Pennsylvania School of Veterinary Medicine to accelerate the development of mRNA-based vaccines and therapies…
Life sciences real estate company PROTECS is acquiring a 35,000-square-foot research and development lab facility in Warminster.
The building is the latest…
A Yardley-based med-tech firm, Astarte Medical, that focuses on software solutions to improve conditions for premature infants, is ceasing operations, writes John George…
A Bucks County biotechnology center pilot program is seeking to bring life sciences companies to the Keystone State, writes John George for the Philadelphia Business…
Warrington-based biopharmaceutical firm Windtree Therapeutics is entering a multimillion-dollar licensing deal with a Chinese drug company for its three new cardiovascular disease drug…
Ryan Sager often monitors the streets of Kensington on a mission to save those battling addiction from overdose deaths, writes Megan Palin for the New…
William Collier, president and CEO of Warminster-based Arbutus Biopharma, will retire from his positions effective December 31, writes John George for the Philadelphia Business…
Katalin Karikó, the Abington scientist whose work led to RNA vaccines that transformed the threat of the COVID-19 pandemic, was awarded the Nobel Prize…
University City-based Vitara Biomedical is currently working on an artificial womb for premature babies and is getting closer to human clinical trials, writes Liz…
Harmony Biosciences Holdings in Plymouth Meeting has agreed to buy Zynerba Pharmaceuticals for up to $200 million, writes John George for Philadelphia Business Journal.
Under…
Before we send you to this site, please subscribe to our daily newsletter.